3-(2,4-dimethoxybenzylidene)anabaseine has been researched along with trans-metanicotine in 2 studies
| Studies (3-(2,4-dimethoxybenzylidene)anabaseine) | Trials (3-(2,4-dimethoxybenzylidene)anabaseine) | Recent Studies (post-2010) (3-(2,4-dimethoxybenzylidene)anabaseine) | Studies (trans-metanicotine) | Trials (trans-metanicotine) | Recent Studies (post-2010) (trans-metanicotine) |
|---|---|---|---|---|---|
| 166 | 8 | 81 | 47 | 0 | 14 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dart, MJ; Holladay, MW; Lynch, JK | 1 |
| Papke, RL | 1 |
1 review(s) available for 3-(2,4-dimethoxybenzylidene)anabaseine and trans-metanicotine
| Article | Year |
|---|---|
Neuronal nicotinic acetylcholine receptors as targets for drug discovery.
Topics: Acetylcholine; Animals; Binding Sites; Dopamine; Drug Design; Humans; Molecular Structure; Nervous System; Neurons; Nicotine; Nicotinic Agonists; Nicotinic Antagonists; Receptors, Nicotinic; Structure-Activity Relationship | 1997 |
1 other study(ies) available for 3-(2,4-dimethoxybenzylidene)anabaseine and trans-metanicotine
| Article | Year |
|---|---|
Enhanced inhibition of a mutant neuronal nicotinic acetylcholine receptor by agonists: protection of function by (E)-N-methyl-4-(3-pyridinyl)-3-butene-1-amine (TC-2403).
Topics: Acetylcholine; Amino Acid Sequence; Animals; Benzylidene Compounds; Electrophysiology; Molecular Sequence Data; Mutagenesis, Site-Directed; Neurons; Nicotine; Nicotinic Agonists; Nicotinic Antagonists; Oocytes; Pyridines; Rats; Receptors, Nicotinic; Sequence Homology, Amino Acid; Transfection; Xenopus laevis | 2002 |